Terlipressin and albumin for the hepatorenal syndrome.

Terlipressin and albumin for the hepatorenal syndrome.

Bibliographic Details
Main Authors:	Antoniades, C, Auzinger, G
Format:	Journal article
Language:	English
Published:	2003

Similar Items

Low doses of terlipressin and albumin in the type I hepatorenal syndrome
by: Davide Pulvirenti, et al.
Published: (2013-05-01)

Noradrenaline or terlipressin for hepatorenal syndrome?
by: Pilar Celis, et al.
Published: (2015-08-01)

Terlipressin in combination with albumin as a therapy for hepatorenal syndrome in patients aged 65 years or older
by: Muhammad A. Mujtaba, et al.
Published: (2023-09-01)

Cutaneous Ischaemia Following Terlipressin Therapy for Hepatorenal Syndrome
by: Aneesh Basheer, et al.
Published: (2018-03-01)

Pharmacokinetic and pharmacodynamic analyses of terlipressin in patients with hepatorenal syndrome
by: Xiaofeng Wang, et al.
Published: (2022-04-01)

Terlipressin effect on hepatorenal syndrome: Updated meta‐analysis of randomized controlled trials
by: Mohamed M G Mohamed, et al.
Published: (2021-08-01)

Terlipressin for the Prevention and Treatment of Renal Decline in Hepatorenal Syndrome: A Drug Profile
by: Ahlam Ayyad, et al.
Published: (2023-09-01)

Severe ischemic bowel necrosis caused by terlipressin during treatment of hepatorenal syndrome
by: Hae Rim Kim, et al.
Published: (2013-12-01)

Endothelin-1/Nitric Oxide Ratio as a Predictive Factor of Response to Therapy With Terlipressin and Albumin in Patients With Type-1 Hepatorenal Syndrome
by: Ahmed Abdel-Razik, et al.
Published: (2020-01-01)

Early treatment with terlipressin in patients with hepatorenal syndrome yields improved clinical outcomes in North American studies
by: Michael P. Curry, et al.
Published: (2023-01-01)

TERLIPRESSIN VERSUS NORADRENALINE FOR HEPATORENAL SYNDROME. Economic evaluation under the perspective of the Brazilian Public Health System
by: Ângelo Zambam de MATTOS, et al.

COMPARISON OF EFFICACY ON NORADRENALINE AND TERLIPRESSIN IN HEPATORENAL SYNDROME IN THE PATIENTS OF DECOMPENSATED CIRRHOSIS – A RANDOMIZED CONTROLLED STUDY
by: Muhammad Siddique, et al.
Published: (2019-08-01)

Role of Terlipressin in Patients With Hepatorenal Syndrome-Acute Kidney Injury Admitted to the ICU: A Substudy of the CONFIRM Trial
by: Constantine J. Karvellas, MD, et al.
Published: (2023-04-01)

Comparative efficacy of terlipressin and norepinephrine for treatment of hepatorenal syndrome-acute kidney injury: A systematic review and meta-analysis.
by: Jody C Olson, et al.
Published: (2024-01-01)

Single Pass Albumin Dialysis in Hepatorenal Syndrome
by: Rahman Ebadur, et al.
Published: (2008-01-01)

CLINICAL EFFICACY OF ALBUMIN DIALYSIS THERAPY FOR PATIENTS WITH HEPATORENAL SYNDROME
by: D. E. Kutepov, et al.
Published: (2009-06-01)

A randomized, placebo-controlled, double-blind study to confirm the reversal of hepatorenal syndrome type 1 with terlipressin: the REVERSE trial design
by: Boyer TD, et al.
Published: (2012-07-01)

Safety and efficacy of terlipressin in acute-on-chronic liver failure with hepatorenal syndrome-acute kidney injury (HRS-AKI): a prospective cohort study
by: Anand V. Kulkarni, et al.
Published: (2022-04-01)

Hepatorenal Syndrome
by: Pınar Zeyneloğlu
Published: (2012-04-01)

HEPATORENAL SYNDROME
by: Matjaž Hafner
Published: (2001-12-01)

Hepatorenal syndrome
by: Andrés Cárdenas, M.D., et al.
Published: (2003-01-01)

Hepatorenal syndrome
by: O.I. Taran
Published: (2014-08-01)

Hepatorenal syndrome: an update
by: Tércio Genzini, et al.

Treatment of hepatorenal syndrome
by: Kezić Aleksandra, et al.
Published: (2007-01-01)

An Update on Hepatorenal Syndrome
by: Samuel Chan, et al.
Published: (2017-03-01)

Noradrenaline and Albumin for Type 1 Hepatorenal Syndrome: A Prospective Study from Eastern Nepal
by: Rabin Sharma, et al.
Published: (2017-08-01)

HEPATORENAL SYNDROME: A REVIEW
by: Diana DIACONESCU, et al.
Published: (2018-06-01)

Comparison of normal saline, hypertonic saline albumin and terlipressin plus hypertonic saline albumin in an infant animal model of hypovolemic shock.
by: Javier Urbano, et al.
Published: (2015-01-01)

An Integrated Review of the Hepatorenal Syndrome
by: Alicia S. Ojeda-Yuren, et al.
Published: (2021-05-01)

HEPATORENAL SYNDROME: DIAGNOSTIC AND THERAPEUTIC MANAGEMENT
by: I. G. Bakulin, et al.
Published: (2016-02-01)

Terlipressin Induced Severe Hyponatremia
by: Martin Šíma, et al.
Published: (2016-01-01)

Terlipressin‐induced foot ischemia
by: Fateen Ata, et al.
Published: (2021-01-01)

Hepatorenal Syndrome: Diagnosis and Treatment – newsreel –
by: Enescu Aurelia, et al.
Published: (2016-09-01)

Comments on the manuscript "Hepatorenal syndrome: an update"
by: Charles Soper

Acute Kidney Injury and Hepatorenal Syndrome
by: Moon Young Kim, et al.
Published: (2018-08-01)

Outcomes of Albumin Use in the Treatment of Acute Hepatorenal Disorders: A Single Center Experience
by: Krishna Pothugunta, et al.
Published: (2017-02-01)

Ramipril poisoning rescued by naloxone and terlipressin
by: Samanta Samanta, et al.
Published: (2014-01-01)

Hepatorenal Syndrome—Novel Insights into Diagnostics and Treatment
by: Krzysztof Badura, et al.
Published: (2023-12-01)

Hepatorenal syndrome: Current concepts and future perspectives
by: Chan-Young Jung, et al.
Published: (2023-10-01)

Is Hepatorenal Syndrome a Diagnosis for the Emergency Physician
by: Andrew F. W. Ho, et al.
Published: (2015-07-01)